Definitive Contract 75N93023C00016

Award Date 7/1/23

Potential Completion Date 6/30/25

Potential Value $5.4M

Federal Agency

National Institute of Allergy and Infectious Diseases

Awardee

Chromologic LLC

Ultimate Awardee

Not listed

NAICS Category

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

PSC Category

AN12 - Health R&D Services; Health Care Services; Applied Research

Federal Contract Vehicle

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Cost Plus Fixed Fee

Place of Performance

Monrovia, CA 91016, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,379,349.00 cost-plus-fixed-fee definitive contract to Chromologic LLC, a minority-owned limited liability company, for the development of MIDOS: A MICRORNA BIODOSIMETER. This contract supports research and development of biodosimetry approaches to assess and medical countermeasures to mitigate or treat acute and/or delayed radiation injuries. The contract aims to develop safe and effective medical countermeasures that can be administered at least 24 hours after radiation exposure, as well as advance biodosimetry biomarkers and devices to inform triage and treatment strategies for mass casualty radiation incidents. This contract is not a set-aside and was awarded under NAICS codes 541711, 541712, or 541715 for research and development in biotechnology or the physical, engineering, and life sciences.

Generated 9/7/24, 12:18 PM

Name	Solicitation Number	Federal Agency	Type	Posted Date (Click to sort descending)
Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices	NIAID-BAA-75N93021R00019	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Solicitation 6/12	4/11/22, 4:41 PM
Development Of Anticeramide Treatment As A Novel Medical Countermeasure For Acute Effects Of Radiation Exposure	NIAID-BAA-75N93021R00019	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 11/12	7/6/23, 12:32 PM
Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices	IB2310_75N93021R00019	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Solicitation 4/12	3/4/22, 4:27 PM
Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices	HHS-NIH-NIAID-BAA-75N93021R00019	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Pre-Solicitation 1/12	11/15/21, 10:31 AM
a microRNA Biodosimeter	NIAID-BAA-75N93021R00019	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 12/12	7/6/23, 12:36 PM

Mod #	Reason For Modification	Federal Obligation (Click to sort descending)	Date (Click to sort ascending)
P00005	Other Administrative Action	$772.1k	8/20/24
P00004	Other Administrative Action	$9.3k	7/8/24
P00003	Exercise an Option	$1.5m	6/3/24
P00002	Funding Only Action	$100.0k	8/23/23
P00001	Other Administrative Action	$0	8/14/23

Plans
Login

Blog